Shanghai Braegen Pharmaceuticals
Developing novel treatments and diagnostics for central nervous system (CNS) disorders like Alzheimer's, Parkinson's, and ALS, with a pipeline including small molecule drugs and radiopharmaceuticals.
HQ location
Huangpu, China
Website
Launch date
Enterprise value
$11—17m
| Date | Investors | Amount | Round |
|---|---|---|---|
* | CNY20.0m | Series A | |
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads